Detalles de la búsqueda
1.
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(10): 1458-1467, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543613
2.
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial.
Int J Cancer
; 147(1): 160-169, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31724170
3.
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2â×â2 factorial, randomised phase 3 trial.
Lancet
; 385(9980): 1863-72, 2015 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25740286
4.
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial.
Breast Cancer Res Treat
; 155(1): 117-26, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26661403
5.
Intermediate clinical endpoints in early-stage breast cancer: an analysis of individual patient data from the Gruppo Italiano Mammella and Mammella Intergruppo trials.
EClinicalMedicine
; 70: 102501, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38685923
6.
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments.
BMC Cancer
; 13: 164, 2013 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23537313
7.
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies.
EClinicalMedicine
; 59: 101931, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37256095
8.
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials.
Clin Cancer Res
; 29(24): 5217-5226, 2023 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37888299
9.
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer.
NPJ Breast Cancer
; 7(1): 82, 2021 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34183674
10.
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers.
Breast Cancer Res Treat
; 124(3): 607-17, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20127405
11.
Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study.
Mod Pathol
; 23(2): 260-9, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19915523
12.
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
Breast Cancer Res Treat
; 117(1): 131-40, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18932017
13.
Axillary Dissection vs. no Axillary Dissection in Breast Cancer Patients With Positive Sentinel Lymph Node: A Single Institution Experience.
In Vivo
; 33(6): 1941-1947, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31662523
14.
Retrospective evaluation of clinical outcomes in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy in the pre-lapatinib era.
Clin Breast Cancer
; 8(5): 436-42, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18952558
15.
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies.
Eur J Cancer
; 71: 34-42, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27951450
16.
Metaplastic breast carcinoma: pathology and clinical outcome.
Anticancer Res
; 23(1B): 669-73, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12680165
17.
Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer.
Breast
; 22(4): 470-5, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23642526
18.
Continuation of trastuzumab beyond disease progression.
J Clin Oncol
; 23(12): 2866-8; discussion 2868-9, 2005 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15838006
19.
Outcome of patients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapy.
Oncologist
; 11(4): 318-24, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16614227
20.
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients.
Breast Cancer Res Treat
; 98(3): 241-8, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16670941